James Investment Research’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$646K Hold
3,408
– – 0.07% 235
2026
Q1
$317K Sell
3,408
-4,873
-59% -$432K 0.04% 292
2025
Q4
$665K Hold
8,281
– – 0.07% 209
2025
Q3
$809K Buy
8,281
+4,305
+108% +$347K 0.09% 185
2025
Q2
$277K Buy
+3,976
New +$227K 0.03% 281
2025
Q1
– Sell
-3,976
Closed -$278K – 327
2024
Q4
$278K Hold
3,976
– – 0.03% 276
2024
Q3
$417K Hold
3,976
– – 0.05% 237
2024
Q2
$565K Buy
3,976
+1,008
+34% +$116K 0.07% 203
2024
Q1
$331K Buy
+2,968
New +$354K 0.04% 255
2018
Q1
– Sell
-50,800
Closed -$1.46M – 775
2017
Q4
$1.46M Buy
+50,800
New +$1.6M 0.05% 442

Other funds holding ACLS

James Investment Research's ACLS Position: Q2 2026 in Review

James Investment Research held its Axcelis (ACLS) position steady in Q2 2026 at 3,408 shares worth $646K. The position accounts for 0.07% of the portfolio, ranked #235.

James Investment Research first reported a position in ACLS in Q4 2017 and has held it in 10 quarters since. The position peaked at $1.46M in Q4 2017. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • James Investment Research held 3,408 shares of Axcelis worth $646K as of Q2 2026.
  • James Investment Research left its Axcelis share count unchanged in Q2 2026.
  • Axcelis made up 0.07% of James Investment Research's portfolio in Q2 2026, its #235 holding.
  • James Investment Research first reported a position in Axcelis in Q4 2017 and has held it in 10 quarters since.
  • James Investment Research's Axcelis position peaked at $1.46M in Q4 2017.
  • 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on James Investment Research's 13F filing for Q2 2026, filed 24 Jul 2026.